Advances in Cell Transplantation Therapy for Diseased Myocardium
2011

Advances in Cell Transplantation Therapy for Diseased Myocardium

publication Evidence: moderate

Author Information

Author(s): Outi M. Villet, Antti Siltanen, Tommi Pätilä, M. Ali A. Mahar, Antti Vento, Esko Kankuri, Ari Harjula

Primary Institution: University of Helsinki

Hypothesis

Can cell therapy improve cardiac function in heart failure?

Conclusion

Cell transplantation using engineered cell sheets shows promise for improving cardiac function and reducing complications compared to traditional injection methods.

Supporting Evidence

  • Cell sheets preserve microcellular communication and matrix, reducing cell loss and arrhythmias.
  • Preclinical studies show that myoblast sheets improve cardiac function in animal models.
  • Engineering of 3D cell constructs is under extensive investigation for better outcomes in cell therapy.

Takeaway

Scientists are trying to fix damaged hearts by using special sheets made of heart cells instead of just injecting cells, which can sometimes cause problems.

Methodology

The study reviews various methods of cell transplantation, including direct injection and the use of engineered cell sheets.

Limitations

The study highlights challenges such as cell loss during injection and the need for better delivery methods.

Digital Object Identifier (DOI)

10.4061/2011/679171

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication